Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection
Authors:
- Sharon C.A. ChenSCSharon C.A. Chen
- Stephen M. BarkerSBStephen M. Barker
- David H. MitchellDMDavid H. Mitchell
- Susan M.B. StevensSSSusan M.B. Stevens
- Peter O’nEillPOPeter O’nEill
- Anthony L. CunninghamAnthony L. Cunningham
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Zidovudine-associated myopathyThe American Journal of Medicine, 1989
- Zidoyudine-Induced HepatotoxicityAnnals of Internal Medicine, 1989
- Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complexJournal of Infection, 1989
- Myopathy Associated with Human Immunodeficiency Virus (HIV) but not with ZidovudineAnnals of Internal Medicine, 1988
- ZIDOVUDINE-ASSOCIATED MYOPATHYThe Lancet, 1988
- Human immunodeficiency virus—associated myopathy: Analysis of 11 patientsAnnals of Neurology, 1988
- NECROTISING MYOPATHY AND ZIDOVUDINEThe Lancet, 1988
- Progressive Nemaline (Rod) Myopathy Associated with HIV InfectionNew England Journal of Medicine, 1987
- Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS)Hepatology, 1987